Speclipse
Seongnam
About Speclipse
Speclipse is a transformative, patented technology for real-time, non-invasive, in-vivo cancer diagnosis utilizing laser spectroscopy and machining learning algorithms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.2M
- Last round: Series Unknown (Aug 2021)
- Website: speclipse.com
- Phone: 82-31-698-2269
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/speclipse-72378 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.